Table 2.
Ring size |
Inhibitor structure | Ki(nM) | IC50(nM)a |
---|---|---|---|
15 | 0.38 ± 0.03 | 120 | |
15 | 0.82 ± 0.03 | 318 | |
14 | 0.082 ± 0.008 | 4 | |
14 | 0.67 ± 0.02 | 49 | |
13 | 0.0045 ± 0.005 | 2 | |
13 | 0.47 ± 0.002 | 22 | |
12 | 0.058 ± 0.005 | 14 | |
12 | 0.017 ± 0.001 | 14 | |
12 | 0.08 ± 0.02 | 23 | |
11 | 0.077 ± 0.004 | 20 | |
11 | 0.15 ± 0.01 | 95 | |
10 | 0.051 ± 0.004 | 15 | |
10 | 0.09 ± 0.01 | 5.5 | |
9 | 2.4 ± 0.3 | n.t.b | |
9 | 1.27 ± 0.03 | 77 |
MT-2 human T-lymphoid cells exposed to HIV-1LAI; Saquinavir and amprenavir exhibited IC50 values of 16 nM and 27 nM, respectively.
n.t. = not tested.